Petmed Express (PETS): Renaissance Technologies LLC cut its PETS stake below 5% (4.8%) 4.8%
Renaissance Technologies LLC cut its PETS stake below 5% (4.8%).
- 4.8%
- Stake
- 1.07M
- Shares owned
- Stake as of
- Jul 1, 2026
- Filed
- Nov 12, 2026
What stands out in this filing
- Reported stake 4.8% (1,070,630 shares).
- The filing reports the stake below 5%, the level at which these reports stop being required.
- A 13G is the short form for a passive owner of more than 5%.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 2, 2026Company filing · Form 8-K · ResultsReported its results
- Jun 8, 2026Insider10% owner purchased ~$44K of PETS shares in the open market
- Jun 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 23, 2026, Leah A. Solivan, a member of the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”), informed the Company of her decision not to stand for reelection at the Company’s 2026 annual meeting of stockholders, which is scheduled to take place on August 11, 2026.”
What came next
- Jul 23, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Aug 11, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On August 11, 2026, the shareholders of PetMed Express, Inc. (the “Company”), upon recommendation of the Company’s Board of Directors (“Board”), approved an amendment to the PetMed Express, Inc. 2024 Omnibus Incentive Plan (“2024 Plan”) to increase the number of shares of common stock reserved for issuance thereunder by 1,800,000 shares (the “2026 Plan Amendment”).”
- Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 15, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 15, 2026, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) appointed Tamar Elkeles, Ph.D., to serve as a director of the Company effective as of September 17, 2026.”
- Sep 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 17, 2026, PetMed Express, Inc. (the “Company”) announced that the Board of Directors (the “Board”) of the Company has appointed Jeffrey Allen Willard as the Company’s new Chief Executive Officer and President.”
- Sep 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective September 27, 2026, the Board of Directors of PetMed Express, Inc. (the “Company”) approved an amendment to the PetMed Express, Inc. 2024 Inducement Incentive Plan (the “Inducement Plan”) to increase the number of shares reserved for issuance under the Inducement Plan by 500,000 shares, resulting in an aggregate of 850,000 total shares reserved for issuance under the Inducement Plan.”
How to read SEC Schedule 13G
A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.
Full guide: Schedule 13D vs Schedule 13G: what is the difference?
What else is on file for Petmed Express
For Petmed Express, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PETS page.
How this filing works
Explore the data
Common questions
What does this filing report about Petmed Express (PETS) stock?
Renaissance Technologies LLC cut its PETS stake below 5% (4.8%). Of the company, Schedule 13G (passive).
When did it happen, and when was it made public?
Stake as of: Jul 1, 2026. Filed: Nov 12, 2026.
What stands out in this filing?
Reported stake 4.8% (1,070,630 shares). The filing reports the stake below 5%, the level at which these reports stop being required. A 13G is the short form for a passive owner of more than 5%.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Schedule 13G, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Petmed Express recently?
For Petmed Express, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the PETS page.
Does this mean PETS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Petmed Express
- SEC Form 4Jun 9, 2026
- SEC Form 4Aug 14, 2025
- SEC Form 4Aug 4, 2025
- SEC Form 4Jul 22, 2025
- SEC Form 4Jul 21, 2025
- SEC Form 4Jul 18, 2025
Everything OQRO holds on this company is on its PETS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
